In March 2018, our paper was featured in the Journal of Alzheimer’s 20th Anniversary Edition. Click on the heading above to read the paper. A simple saliva analysis and at risk results could provide information to take action to spare oneself of Alzheimer’s Disease!
A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels, click on Breaking News above! Published in the Journal of Alzheimer's Disease, and subsequently picked up globally by other reputable medical science journals. It was the most read paper in December 2016 by Medical Geneticists, according to Medscape (January 2017).
One of the most aggressive forms of breast cancer, further challenged by minimal therapies available to suppress the beast. Help us raise $10,000 to test TNBC Cancer Cells for 2 levels of testing in-vitro with a new non-toxic compound, which will assess effectiveness to target the enemy.
We have changed our name to better reflect our focus, Neuro-medical research, which will still encompass diseases of cancer and degenerative disease, just through a more precise scope of research. Our directors look forward to receiving vetted cutting edge proposals, and donors still have the flexibility of choosing where their donation is directed.